Method and composition for inhibiting arteriosclerosis
Abstract
The present invention has for its object to provide a method and a composition for achieving a more efficient recovery of the antioxidant activity of plasma LDL, or even augmentation thereof, which has been depressed by the use of an antihyperlipidemic or cholesterol-lowering drug to thereby insure a potentiated antiarteriosclerotic efficacy. A method for inhibiting arteriosclerosis, which comprises using a combination of a cholesterol-lowering agent and a reduced coenzyme Q 10 represented by the following formula (1), and a composition for inhibiting arteriosclerosis containing both a cholesterol-lowering agent and said reduced coenzyme Q 10 .
Claims
exact text as granted — not AI-modified1 . A method for inhibiting arteriosclerosis, which comprises using a combination of a cholesterol-lowering agent and a reduced coenzyme Q 10 represented by the following formula (1).
2 . The method according to claim 1 ,
wherein the cholesterol-lowering agent is a hydroxymethylglutaryl-CoA reductase inhibitor.
3 . A composition for inhibiting arteriosclerosis, which comprises both a cholesterol-lowering agent and a reduced coenzyme Q 10 represented by the following formula (1).
4 . The composition according to claim 3 ,
wherein the cholesterol-lowering agent is a hydroxymethylglutaryl-CoA reductase inhibitor.Join the waitlist — get patent alerts
Track US2004010047A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.